Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Phase II Study Evaluating Tolerability in Prostate Cancer Patients Treated With Abiraterone + Prednisone or Darolutamide

NCT06173362 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06173362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06173362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Phase II Study Evaluating Tolerability in Prostate Cancer Patients Treated With Abiraterone + Prednisone or Darolutamide
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Recruiting
Start date
November 9, 2023
Completion date
May 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate adenocarcinoma, stage iii prostate cancer ajcc v8, stage iv prostate cancer ajcc v8